Safety signals using proportional reporting ratios from company and regulatory authority databases

Drug Information Journal

Volumn 42, Issue 3, 2008, Pages 205-210

  Czarnecki, Andrzej ^a   Voss, Simon ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Adverse reaction; Pharmacovigilance databases; Proportional reporting ratio

Indexed keywords

ARTICLE; AUTHORITY; DATA BASE; DRUG INDUSTRY; DRUG INFORMATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 44649101942     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150804200301     Document Type: Article

References (16)

1. Evans SJW. Pharmacovigilance: a science or fielding emergencies? Stat Med. 2000;19:3199-3209.
2. Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Safety. 2005;14:285-286.
3. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Safety. 2001;10:483-486.
4. Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over proportional reporting ratio. Pharmacoepidemiol Drug Safety. 2004;13:519-523.
5. van Puijenbroek E, Bate A, Leufkens HGM, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Safety. 2002;11:3-10.
6. Waller P, van Puijenbroek E, Egberts A, et al. The reporting odds ratio versus the proportional reporting ratio: "deuce." Pharmacoepidemiol Drug Safety. 2004;13:525-526.
7. Roux E, Thiessard F, Fourrier A, et al. Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Inf Technol Biomed. 2005;9(4):518-527.
8. Almenoff J, Tonning JM, Gould L, et al. Perspectives in the use of data mining. Pharmacovigilance Drug Safety. 2005;28:981-1007.
9. Strom BL, Kimmel SE, eds. Textbook of Pharmacoepidemiology. Chichester, UK: Wiley & Sons; 2006.
10. Kilgour-Christie J, Czarnecki A, Simmons V. Proportional reporting ratio calculations from a pharmaceutical company database. Pharmacoepidemiol Drug Safety. 2001;10(Suppl 1):S159.
11. Kilgour-Christie J, Czarnecki A. Safety signals verified using PRRs on regulatory authority databases. Pharmacoepidemiol Drug Safety. 2002;11 (Suppl 1):S145-S146.
12. Rodriguez EM, Staffa JA, Graham DJ. The role of databases in drug postmarketing surveillance. Pharmacoepidemiol Drug Safety. 2001;10:407-410.
13. FDA Adverse Event Reporting System (AERS). Available at: http://www.fda.gov/cder/aers/default.htm. Accessed September 13, 2005.
14. Wood SM, Coulson R. Adverse drug reactions online information tracking (ADROIT). Pharm Med. 1993;7:203-213.
15. Dean AD, Dean AJ, Dicker RC. Epi Info Version 5: A Word Processing, Database and Statistical Program for Epidemiology on Microcomputers. Atlanta, GA: Centers for Disease Control; 1990.
16. Medicines Control Agency. 2001. Available at: http://www.accenture.com/ Countries/UK/Services/By_Subject/Infrastructure_Outsourcing/Client_Successes/ MedicinesEcommerce.htm. Accessed May 2, 2006.